Alphanox to Acquire Additional Shares of U.S. Subsidiary for 5.6 Billion KRW
Alphanox announced on the 19th that it will acquire an additional 4 million shares of its U.S. implant sales subsidiary (Solco Biomedical) for approximately 5.6 billion KRW.
After the acquisition, Alphanox's ownership stake will become 100%. The scheduled date of share acquisition is the 23rd.
Hot Picks Today
"I Ate It Often Because It Tasted Good"... This Eating Habit Linked to 40% Higher Odds of Asymptomatic Cerebrovascular Damage
- "Booked a Cheap Flight, Only to Get Blindsided"... Travelers' Complaints "Explode" Over Extra Fees
- Woman in Her 70s Assaults Sister in Her 80s: “She Had an Affair with My Husband”
- “Dad Just Gave It to Us as a Gift”... Scratched a Lottery Ticket at a Family Gathering and Hit a 1 Billion Won Jackpot
- "We've gone this far to save on lunch"... Where office workers are flocking instead of restaurants
The company stated that the purpose of this acquisition is to strengthen business competitiveness in the U.S. market and to improve its financial structure.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
!["Please, Just Take Them Off" - They Made It All the Way to Bed... Then Fecal Bacteria Struck [Deep Scroll]](https://cwcontent.asiae.co.kr/asiaresize/307/2026101610053063338_1792112730.png)
